Therapeutics

Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, June…

LEAD PLAINTIFF DEADLINE IS JULY 25, 2022 NEW YORK, June 9, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Spero Therapeutics, Inc.…

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, PC, a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. (“Spero” or the “Company”)…

NEW YORK, May 30, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO) and certain of its officers. The class action, filed in…

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Axsome Therapeutics, Inc. (NASDAQ: AXSM) securities between December 30, 2019 and April 22, 2022, inclusive (the “Class…

NEW YORK, April 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed…

NEW YORK, March 26, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia Therapeutics, Inc. ("Akebia" or the "Company") (NASDAQ: AKBA) and certain of its officers. The class action, filed…

LEAD PLAINTIFF DEADLINE IS MAY 13, 2022 NEW YORK, March 24, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Akebia Therapeutics, Inc.…

SAN DIEGO--(BUSINESS WIRE)-#RVNCstock-Robbins Geller Rudman & Dowd LLP announces that purchasers of Revance Therapeutics, Inc. (NASDAQ: RVNC) securities between November 25, 2019 and October 11, 2021, inclusive (“Class Period”) have…

NEW ORLEANS, Feb 4, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former…